ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Proven Process For Managing Clinical Trial Changes, Data Migrations

  Explore how the Imperial College London was able to complete a successful migration of 14 ongoing studies, involving over 1,700 patients and 150,000+ forms, within a 16-month timeframe.

• Addressing The Specific Complexities Of Oncology eCOA Clinical Trials

  What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.

• Considerations For Implementing The Best eCOAs In Your Trial Design

  Dive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.

• The Future Of eCOA & Wearable Devices

  Learn how by looking at the advantages of wearables and where they are headed in the future, manufacturers, providers, and researchers can better anticipate collaboration efforts to bridge the gaps in existing processes and maximize the potential of eCOA wearables in clinical research.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

• Using IRT Data To Automate And Optimize Clinical Supply

  Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.

• Clinical Trial Startup: Insights From The Industry

  Uncover key survey findings gleaned from the perspectives of over 500 clinical researchers regarding technological trends and recommendations for enhancing the overall site experience.

• Timely Lab Data To Inform Outreach To Healthcare Professionals

  Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.

• Early-Stage Biotech's AI Advantage Is A Window That Closes

  FDA AI guidance won’t build your strategy for you. Learn how biotech teams can avoid retrofits and design smarter clinical AI from day one.

• How AI Activates The Full Potential Of Wearables In Clinical Research

  Wearables provide continuous real‑world insights, and AI turns raw sensor data into meaningful evidence. With unified data infrastructure, studies gain more reliable, patient‑centered endpoints.